Category: Latest News

  • Kymera Therapeutics Shares Surge 37% on Promising KT-621 Trial Results

    Kymera Therapeutics Shares Surge 37% on Promising KT-621 Trial Results

    Kymera Therapeutics Inc. (NASDAQ:KYMR) saw its stock jump 37.3% in premarket trading after the company announced strong Phase 1 trial results for KT-621, its oral STAT6 degrader targeting allergic and inflammatory diseases. The trial demonstrated that KT-621 achieved over 90% average STAT6 degradation in blood at doses above 1.5 mg and complete degradation in both…

  • Palantir Stock Hits Record High of $133.55 on Strong Earnings and Expanding Contracts

    Palantir Stock Hits Record High of $133.55 on Strong Earnings and Expanding Contracts

    Palantir Technologies Inc. (NASDAQ:PLTR) surged to an all-time high of $133.55, driven by exceptional earnings and sustained growth in both government and commercial sectors. The stock’s meteoric rise has pushed the company’s market capitalization to $311 billion, underscoring investor confidence in Palantir’s expanding role in the data analytics and AI ecosystem. The stock is up…

  • CAE Appoints Northrop Grumman Executive Matthew Bromberg as New CEO

    CAE Appoints Northrop Grumman Executive Matthew Bromberg as New CEO

    CAE Inc. (NYSE:CAE), the Canadian aviation and defense technology company, has named Matthew Bromberg as its next chief executive officer. Currently a senior executive at Northrop Grumman (NYSE:NOC), Bromberg will officially assume the role on August 13, taking over from Marc Parent, who has led CAE since 2009 and announced his planned departure in November.…

  • Amazon’s Pricing Tools Face Antitrust Scrutiny in Germany

    Amazon’s Pricing Tools Face Antitrust Scrutiny in Germany

    German competition authorities are scrutinizing Amazon’s (NASDAQ:AMZN) pricing tools, citing concerns that the mechanisms could breach competition laws. The Federal Cartel Office raised issues with how Amazon’s marketplace algorithms highlight competitively priced products while potentially downranking or removing listings deemed too expensive. Amazon operates a vast marketplace featuring products from both third-party sellers and the…

  • Blueprint Medicines Stock Surges as Sanofi Announces $9.5 Billion Acquisition

    Blueprint Medicines Stock Surges as Sanofi Announces $9.5 Billion Acquisition

    Shares of Blueprint Medicines Corp. (NASDAQ:BPMC) soared 26.5% after Sanofi (NASDAQ:SNY) revealed plans to acquire the biopharmaceutical company in a deal valued at approximately $9.5 billion. The acquisition strengthens Sanofi’s rare disease and immunology portfolio, while adding a promising pipeline of early-stage immunology assets. Under the terms of the agreement, Sanofi will pay $129.00 per…

  • Alphabet Shares Dip Amid Uncertainty Over Antitrust Case

    Alphabet Shares Dip Amid Uncertainty Over Antitrust Case

    Shares of Alphabet Inc. (NASDAQ:GOOGL) dropped 2% as uncertainty lingers over the outcome of a high-profile federal antitrust trial. During a recent hearing, U.S. District Judge Amit Mehta suggested he may consider less drastic measures than those proposed by the Department of Justice (DOJ) to curb Google’s dominance in online search and advertising. The judge…

  • Liquidia Shares Climb After First Commercial Shipment of YUTREPIA

    Liquidia Shares Climb After First Commercial Shipment of YUTREPIA

    Liquidia Technologies Inc (NASDAQ:LQDA) saw its shares rise nearly 10% following news that it will begin its initial commercial shipments of YUTREPIA™ (treprostinil) inhalation powder. This milestone follows FDA approval granted on May 23, 2025, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension linked to interstitial lung disease (PH-ILD). The product will…

  • ATAI Life Sciences Shares Jump Following Merger Announcement with Beckley Psytech

    ATAI Life Sciences Shares Jump Following Merger Announcement with Beckley Psytech

    ATAI Life Sciences BV (NASDAQ:ATAI) experienced an 18.6% surge in its stock price after announcing a planned merger with Beckley Psytech, a strategic move aimed at forming a global leader in psychedelic-based mental health treatments. The all-stock deal, expected to close in the latter half of 2025, will result in a combined company named atai…

  • Cactus to Acquire Majority Stake in Baker Hughes’ Surface Pressure Control Unit

    Cactus to Acquire Majority Stake in Baker Hughes’ Surface Pressure Control Unit

    Cactus Companies (NYSE:WHD), a subsidiary of Cactus, announced plans to purchase a 65% controlling interest in Baker Hughes’ (NASDAQ:BKR) Surface Pressure Control (SPC) business. The transaction, valued at $344.5 million, will result in Baker Hughes retaining a 35% ownership stake in the SPC unit after closing. The overall enterprise value of the deal is approximately…

  • Applied Digital Stock Climbs 13% on Major AI Data Center Lease Deal with CoreWeave

    Applied Digital Stock Climbs 13% on Major AI Data Center Lease Deal with CoreWeave

    Shares of Applied Digital Corporation (NASDAQ:APLD) surged 13% after the company announced a landmark lease agreement involving its forthcoming AI-focused data center in North Dakota. Applied Digital revealed it has signed two long-term leases, each spanning around 15 years, with CoreWeave – a prominent provider in artificial intelligence (AI) and high-performance computing (HPC) – to…